2026

Articles
Title
NAM CHEONG +42% YTD: Why DBS Still Sees It as a Buy with $1.90 Target
ANALYSTS SAY: Buy, Sell, Hold (22 May)
YANGZIJIANG: Orders, Dividends, and Expansion: Why Analysts Are Bullish on This Maritime Stock
ANALYSTS SAY: Buy, Sell, Hold (21 May)
Unlocking Value: iX Biopharma Creates Standalone US Business With Potential Spin-Off or Listing
ANALYSTS SAY: Buy, Sell, Hold (20 May)
Insights from the RHB Top 20 Singapore Small Cap Jewels 2026 report
ANALYSTS SAY: Buy, Sell, Hold (19 May)
Sasseur REIT Breaks Records in Q1: Here’s How They Did It
ANALYSTS SAY: Buy, Sell, Hold (18 May)